EV
Eric Venker (President & Immunovant CEO) filed 17 Form 4 reports in the trailing twelve months (0 purchases, 17 sales, 1 filed past the two-business-day deadline), most often in Roivant Sciences Ltd. (ROIV). The largest single filing was $7.3M of ROIV (200,000 sh × $36.62, as filed), executed Sep 30. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
17
0 buys · 17 sells · 1 late
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$87.9M
shares × price, as filed
Last traded
Nov 3
Filed Nov 5
Median ADV $222.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $181.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
17 filings
Sector per market data · by filing · past 12 months
Most traded names
ROIVRecent filings
ROIVSALE
Roivant Sciences Ltd.
View filing →
$6.6M200,000 sh across 2 lots
Exec Jun 24
Filed Jun 26 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $6.1M
200,000 sh × $30.27
Exec May 22
Filed May 22 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $5.9M
200,000 sh × $29.59
Exec Apr 20
Filed Apr 22 · 5:30 PM ET IMVTSALE Immunovant, Inc. View filing → $308K
12,820 sh × $24.04
Exec Apr 2
Filed Apr 3 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $5.6M
200,000 sh × $28.24
Exec Mar 17
Filed Mar 19 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $5.3M
200,000 sh × $26.49
Exec Feb 13
Filed Feb 18 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $4.4M
200,000 sh × $21.92
Exec Jan 12
Filed Jan 14 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $6.2M
275,000 sh across 2 lots
Exec Dec 23 2025
Filed Dec 29 2025 · 5:30 PM ET † More filings →